AlphAIAlphAI — Financial news for AI agents
benzinga.comSEP 142 min read$COIN

This Coinbase Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Monday - Coinbase Global (NASDAQ:

Compass Point upgraded Coinbase (COIN) to Neutral with a $177 price target, up from $130. Other upgrades include 4D Molecular Therapeutics (FDMT), Affirm (AFRM), Chime Financial (CHYM), and Bullish (BLSH) by their respective analysts. COIN closed at $175.26 on Friday.

Original reporting
benzinga.com
Published Sep 14, 2026, 12:31 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 14, 2026, 3:30 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefFinancial news
Primary signal
$COIN
Bullish
medium confidence
Mentioned
$COIN · $FDMT · $AFRM · $CHYM · $BLSH
Relevance
7/10
AlphAI data visualization · based on benzinga.com
Decision brief

The 30-second read

$COINBullishMed
01

Why it matters

Upgrades provide fresh valuation guidance and may trigger short‑term price moves as investors adjust positions.

02

Market read

The upgrades collectively suggest a bullish tilt in analyst sentiment for mid‑cap growth stocks, potentially prompting buying pressure.

03

What to watch

Potential regulatory risks for crypto‑related firms and clinical trial timelines for biotech firms.

Relevance 7/10Novelty 7/10Timing: Monday

Background

The article compiles recent analyst rating upgrades for five U.S.-listed companies across fintech, crypto, and biotech.

Company-level read

Ticker impact

$COINBullishMedium confidence
Context

Compass Point analyst upgraded Coinbase (COIN) from Sell to Neutral with a $177 price target.

Expected impact

Potential upside toward $177 target.

Evidence & confidence

Analyst raised target reflecting better market conditions for the crypto exchange.

$FDMTBullishMedium confidence
Context

Cantor Fitzgerald analyst upgraded 4D Molecular Therapeutics (FDMT) from Neutral to Overweight with a $20 price target.

Expected impact

Shares may rally toward $20 target.

Evidence & confidence

Higher rating and target reflect positive expectations for upcoming data.

$AFRMBullishMedium confidence
Context

Wolfe Research analyst upgraded Affirm (AFRM) from Peer Perform to Outperform with a $90 price target.

Expected impact

Potential price appreciation toward $90.

Evidence & confidence

Analyst sees stronger growth prospects and improved profitability.

$CHYMBullishMedium confidence
Context

Rothschild & Co analyst upgraded Chime Financial (CHYM) from Neutral to Buy with a $46 price target.

Expected impact

Shares could move toward $46.

Evidence & confidence

Analyst expects continued user acquisition and revenue expansion.

$BLSHBullishMedium confidence
Context

Compass Point analyst upgraded Bullish (BLSH) from Neutral to Buy with a $51 price target.

Expected impact

Potential upside toward $51.

Evidence & confidence

Higher target driven by anticipated earnings growth.

Market effects

Sector

Analyst upgrades may lift sentiment across fintech and biotech sectors.

Regional

U.S. market participants likely to react positively to the upgrades.

Global

Positive rating changes could influence global investor perception of U.S. growth stocks.

Counterpoint

What could challenge this read

Some investors may view the upgrades as premature given broader market volatility.

Key entities

  • company
    Coinbase Global Inc

    US‑listed crypto exchange (COIN).

  • company
    4D Molecular Therapeutics Inc

    Biotech firm (FDMT).

  • company
    Affirm Holdings Inc

    Buy‑now‑pay‑later provider (AFRM).

  • company
    Chime Financial Inc

    Neobank (CHYM).

  • company
    Bullish

    Financial services firm (BLSH).

Read at source← All news

Related articles

OCT 28
$COINMed

A dollar-linked token has passed $2.6 billion in market value and is now on Coinbase.

Ripple's stablecoin, RLUSD, has surpassed $2.6 billion in market value and is now available on Coinbase's platforms. The partnership allows retail and institutional clients to trade and manage RLUSD. Ripple and Coinbase aim to expand market access and utility for the stablecoin, which is regulated and redeemable for USD. RLUSD is supported across the XRP Ledger, Base, and Ethereum.

stocktitan.net4 min
OCT 28
$COINLow

Coinbase denies systems breach, says vendor exposed customer data

Coinbase reported a security incident at vendor Amplitude, exposing contact info of some customers. Coinbase denied a breach of its own systems and stated funds were unaffected. The incident is part of broader cyberattack reports affecting financial firms. In May 2025, Coinbase disclosed another breach with up to $400M in costs.

tradingview.com2 min
OCT 27
$COINHigh

Coinbase’s One-Time MiCA Stablecoin Conversion Runs Friday for EEA Users

Coinbase (COIN) will convert 14 stablecoins in EEA retail accounts to USDC or other supported assets on Oct. 30, as they do not comply with EU's MiCA rules. Users must withdraw tokens by the deadline to avoid automatic conversion. The exchange previously restricted trading of these tokens. Coinbase Luxembourg S.A. is authorized under MiCA, but the transitional period for stablecoin issuers ended in July 2026.

finance.yahoo.com2 min
OCT 26
$MSTRMed

Strategy Sinks 2% as It Pauses Bitcoin Buying Amid “Risk Off” Crypto Slide

Strategy (MSTR) shares fell slightly as it reported no bitcoin purchases last week, spending $204.9M on preferred stock buybacks. Its USD Cash dropped to $242.4M. Bitcoin fell below $80K, affecting Coinbase (COIN) and other crypto-related stocks. Strategy's funding strategy is paused until its STRC stock recovers to $100. Q3 earnings are due Oct. 29, but MSCI's Nov. 11 index review is a key event.

finance.yahoo.com2 min